Microbot Medical (NASDAQ:MBOT) Announces Quarterly Earnings Results

Microbot Medical (NASDAQ:MBOT) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Stock Down 0.6 %

Shares of MBOT traded down $0.01 during trading hours on Tuesday, hitting $1.59. The company had a trading volume of 759,230 shares, compared to its average volume of 1,767,746. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The stock’s 50 day moving average price is $1.75 and its 200 day moving average price is $1.30. The firm has a market cap of $55.24 million, a P/E ratio of -1.99 and a beta of 1.60.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright upped their price objective on shares of Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.